Pre-treatment of hyponatremia as a biomarker for poor immune prognosis in advanced or metastatic gastric cancer: A retrospective case analysis
Hyponatremia, a prevalent electrolyte imbalance among tumor patients, has often been overlooked regarding its prognostic significance for immunotherapy. In this study, we delved into the prognostic ramifications of hyponatremia in advanced gastric cancer (AGC) patients undergoing immunotherapy. Enro...
Saved in:
| Main Authors: | Yuting Pan, Yue Ma, Huafang Guan, Guanghai Dai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2414546 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computed tomography radiomics to predict microsatellite instability status and immunotherapy response in gastric cancer
by: Zhou Li, et al.
Published: (2025-08-01) -
Tissue Biomarkers in Gastric Cancer Treatment: Present and Future
by: Giulia Airò, et al.
Published: (2024-11-01) -
VCAM-1 predicts poor prognosis and modulates immune infiltration in gastric cancer: a TCGA-based bioinformatics study
by: Cheng Wu, et al.
Published: (2025-08-01) -
LDH and glycolytic activity as predictors of immunotherapy response in gastric cancer: a systematic review and meta-analysis
by: Li Zhu, et al.
Published: (2025-06-01) -
Multidisciplinary analysis of the prognosis and biological function of NUBPL in gastric cancer
by: Luqian Liu, et al.
Published: (2025-06-01)